VBS
VECTUS BIOSYSTEMS LIMITED
$0.1100
0.00%
Market cap
$7M
Turnover
—
Last price
$0.1100
Day change
0.00%
Announcements
7
Range, past year
Open 0.060 · Low 0.037 · Now 0.110 · High 0.455
Open VBS in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
VBS momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-29.
Momentum quality
24/100
Wyckoff phase
Downtrend4d
Trend stage
Breakdown
1 Day
+0.0%
1 Week
-21.4%
1 Month
-40.5%
1 Year
+83.3%
RSI
36
Avg daily range
13.2%
VECTUS BIOSYSTEMS LIMITED scores 24 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Breakdown.
On the Wyckoff cycle it sits in Downtrend, where it has been for 4 trading days. The weekly timeframe reads Downtrend, which agrees with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -50.0%
- High volatility (ATR 13.2%)
- Risk rating: Very High
- Composite downside risk elevated
Browse the whole market by signal:
ASX stocks in Wyckoff accumulationASX momentum stocks by trend qualityASX stocks breaking outASX stocks near 52-week highsVBS announcements
Recent price-sensitive releases.
- 2026-08-31 Preliminary Final Report Preliminary Final Report
- 2026-05-22 Placement of Shares
- 2026-05-07 Appointment of Dr Tara Speranza as CEO & CTO
- 2026-04-30 Quarterly Activities & Appendix 4C Cash Flow Reports
More Health Care stocks
Most traded in the same sector.